Introduction
Growth and differentiation of hematopoietic cells are regulated by a complex network of interactions involving cytokines and a variety of microenvironmental factors. Signals initiated at the cell surface from either cytokine receptors or adhesion molecules are transduced to the nucleus via phosphorylation of cytoplasmic proteins. For the class III receptor tyrosine kinases (RTK), signal transduction involves the participation of intrinsic protein tyrosine kinase activity.
1 FLT3 2,3 and KIT 4, 5 belong to the class III RTK; they encode the receptors for FL (FLT3 ligand) and for SCF/KL (stem cell factor/KIT ligand) respectively. 6 Ectopical expression of a receptor in a cellular environment physiologically associated to a closely related receptor, is a potential way to define shared transduction pathways between these two receptors. It also represents an opportunity to establish a relationship between such transduction pathways and various receptor-associated functions.
FLT3 and KIT are expressed on highly enriched hematopoietic stem cell populations (HSC) [7] [8] [9] [10] [11] and each of them may participate in the activation of lineage-specific developmental programs. FL, in combination with other cytokines such as IL7, IL11 and KL, allows the proliferation and differentiation of early B cell progenitors. [12] [13] [14] [15] [16] In addition, FLT3 knock-out mice show a defect in the steady state numbers of CD43 + pro-B cells and in the repopulation of the lymphoid lineages, 17 indicating the specific involvement of the FLT3/FL receptor/ligand pair in B lymphoid differentiation. In contrast, analysis of W (White spotting) mutant mice, deficient in KIT receptor function, revealed essential functions of KIT in hematopoiesis, melanogenesis and germ cell maturation. 18 In hematopoietic differentiation, W mutants show defects in very early multilineage progenitors, early and late erythropoiesis, Correspondence: P Dubreuil; Fax: 33 491 260 364 Received 12 January 1997; accepted 3 January 1998 as well as in the development and function of mast cells. 18, 19 Activation of KIT in normal mast cells stimulates different responses, their proliferation, [20] [21] [22] survival, 23 and/or differentiation. 20, 21, 24, 25 KIT also participates in mast cell adhesion to extracellular matrix laid down by fibroblasts. [26] [27] [28] [29] The synergistic activities exerted by FLT3 and KIT on a small fraction of cycling HSC suggest that a common transduction pathway exists at an early stage of HSC differentiation, and which results in the expansion of the specific committed progenitor population. In later steps of the differentiation pathway, B cell development requires specific FLT3 signaling, while KIT directs the maturation of the erythroid and mast cell lineages.
The specialized functions of each individual receptor may involve the molecules involved in their respective transduction pathways, thus making it critical to define the specific molecular basis of signaling through each receptor. One direction that we and others have explored, is to determine the nature and the corresponding functions of the cytoplasmic transduction pathways activated in response to FL or KL. [30] [31] [32] [33] [34] Coexpression of both receptors into the same hematopoietic cell population could help us to analyze the possible crosstalk between the two transduction pathways. To this purpose, we expressed a chimeric receptor, FF3, composed of the FMS/CSF1R ligand binding ectodomain fused to the transmembrane and cytoplasmic domains of mFLT3, 35 in mast cell populations derived from fetal liver and bone marrow, from W/W, as well as wild-type mice. We show that KIT and FLT3 share some common activities, but that KIT ensures some specific and specialized functions in mast cells.
Materials and methods
Derivation and characterization of murine mast cells W/+ (White spotting) mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and were crossed to obtain homozygote animals. Murine bone marrow or fetal liver cells were grown in the presence of recombinant murine interleukin 3 (rmIL3) as described. [36] [37] [38] [39] [40] In order to obtain W/W mast cells, fetal livers from 15-day embryos were recovered from pregnant W/+ females and crushed by repeated pipetting through a 23 G needle. Mast cells were expanded by seeding the cellular suspension at 2 × 10 6 cells/ml in mast cell medium (MCM): OptiMEM (Life-Technologies, Cergy-Pontoise, France), 5.5 × 10 −5 m ␤-mercaptoethanol, 5% FCS, 100 UI/ml penicillin, 100 g/ml streptomycin, and 1.25 ng/ml of rmIL3 (1% of conditioned medium (CM) from X63 cells as a source of rmIL3). 41 This conditioned medium was titrated against rmIL3 (R&D Systems Europe, Oxon, UK) showing a linear relationship. These results indicate also that the X63 CM does not contain additional mast cell activating cytokines (see Results). After 3 weeks of culture, IL3-dependent persisting cells were subjected to retroviral infection (see below). Then, over 95% of infected cells were phenotyped as mast cells by histochemical staining using alcian-blue, 42 and by surface detection of mast cell markers such as Fc␥RII/RIII and KIT receptors, using FACS analysis. Mast cell populations were kept growing in culture over a 6-month period.
Infection of W/W mutant and wild-type mast cells
The replication defective LXSN retrovirus vector 43 was used to subclone the FF3 receptor (LXSN FF3), a chimeric molecule composed of the FMS/CSF1R ligand binding ectodomain fused to the transmembrane and cytoplasmic domains of mFLT3. 35 LXSN-FF3 and LXSN vectors were transfected into the GP+E−86 ecotropic packaging (3T3 derived) cell line. 44 Producer clones with retroviral titers higher than 5 × 10 5 G418 forming units/ml were selected. Infection of mast cells was performed as described, 45 except that packaging cells were treated with mitomycin C (10 g/ml for 3 h). Before infection, mast cells were treated with protamine sulfate (2 g/ml for 1 h). They were centrifuged, resuspended in MCM and added over the packaging cells. Coculture was continued for a 10-day period and infected cells were selected using 1 mg/ml of G418 for 15 days. Purity of transduced cells were estimated using FACScan cytofluorimeter analysis (see below) by the expression of the FF3 receptor.
Cell surface immunostaining and flow cytometric analysis Cells (2.5 × 10 5 ) were washed in PBS supplemented with 5% FCS and 0.2% sodium azide (PBSF) and resuspended in 50 l of the same buffer. Anti-murine CSF1R 7D6-3D monoclonal antibody (MoAb), (UBI, Lake Placid, NY, USA) was diluted 1:10 in PBSF and added to the cell suspension for 30 min at 4°C. Cells were washed three times in PBSF and incubated for 30 min at 4°C in a 1:50 dilution of polyclonal phycoerythrinlabelled goat anti-rat antibody (Immunotech, Marseille, France). After three washes in PBSF, pellets were resuspended in 250 l PBS containing 2% formaldehyde. Cells were analyzed on a FACScan cytofluorimeter (Becton Dickinson, San Jose, CA, USA). KIT expression was monitored using the ACK2 MoAb (gift from Dr Nishikawa, Cergy-Pontoise, France and also purchased from Life-Technologies). Fc␥RII/RIII surface expression was analyzed using the FITC-labeled 2.4G2 MoAb (Pharmingen, San Diego, CA, USA). rhCSF1 was a gift from Chiron and was used routinely at 200 ng/ml, rmKL was a gift from S Lyman (Immunex) and used at 250 ng/ml, rmIL3 (R&D Systems Europe, UK) or X63-CM were used at 1.25 ng/ml or 1% final dilution, respectively.
Measurement of proliferative response to growth factors

Adhesion to fibronectin
Adhesion assay of mast cells was modified from that already described. 46 
Characterization and maturation analyses of cultured mast cells (CMC)
Infected mast cells were maintained in MCM supplemented either with IL3 (1% of conditioned medium from X63 cells) or 250 ng/ml KL or 200 ng/ml CSF1. Two weeks after initiation of the maturation culture assay, total RNA was prepared for each set of cells using the RNA-B solution following instructions of the manufacturer (Bioprobe Systems, Montreuil, France). PCR amplification reactions were performed on 2.5 g of reverse-transcribed RNA from each condition as described. 47 Primers used were derived from published sequences of the different mast cell proteases. Genes, oligonucleotide sets and expected product sizes are as follows: mMC-CPA sense (GGACTGTGGCATTCATGCACG) and anti-sense (CATCCGTGGCAATCCTTGCAA) oligonucleotides (497 bp), 48 mMCP-6 sense (GCTCTCTCATCCACCCACAGT) and antisense (GCAGCCAGGTACCCTTCACTT) oligonucleotides (532 bp), 49 mMCP-4 sense (GGTGGTGTTGAGTCTAGACCA) and anti-sense (GCACATATGAGGAGATTCGGG) oligonucleotides (643 bp).
50,51 PCR fragments were analyzed by Southern blotting using ␥-32 P end-labeled primers. Primers derived from an internal PCR-insert sequence were the following: mMC-CPA-Hyb (GCACCAGAGTCTGAGAAAGAG), mMCP-6-Hyb (GAAGTACCACACTGGCCTCTA), and mMCP-4-Hyb (CGA-ACTGGAGTGACAGAACCT).
To determine W genotype, RT-PCR was performed on each mast cell population resulting from a W/+ cross fetus, using the following PCR primers: KIT sense (GCCTTC-TTTAACTTTGCATTTAAAG) (cDNA positons 1541-1565) and anti-sense (GCTCGTCATCTTCCATGATGGC), (cDNA positions 2284-2316) oligonucleotides as described. 52 One PCR product of 766 bp is obtained with mast cells from wild-type animals, two fragments (659 bp and 532 bp) with W/W homozygotes and the three fragments with heterozygote mice. 52 
Results
Ectopic expression of the FF3 tyrosine kinase receptor at the surface of IL3-dependent murine mast cells Cultured murine mast cells normally express the KIT receptor but not the FLT3 or FMS receptors as assayed by RT-PCR (data not shown). We and others previously demonstrated that ectopic expression of FLT3 in IL3-dependent hematopoietic cell lines such as BaF/3 or FDCP1, induces IL3-independent growth and FLT3-dependent proliferation. 32, 33, 53, 54 To analyze the possibility for FLT3 to substitute for KIT function(s) in cultured primary murine mast cells, mast cell ectopically expressing FLT3 were obtained by retroviral infection. As antibodies against the murine FLT3 molecule were not yet developed, a chimeric FMS-FLT3 (FF3) molecule (described in Materials and methods) was used in place of FLT3 and its expression detected using an anti-mFMS MoAb. We and others previously showed that FF3 transduces both biochemical and biological signals in response to CSF1. 32, 33, 54 Retroviral infection of the mast cell population, followed by G418 selection, led to cell population where 89% of the cells were positive for FF3 expression, at levels comparable to those of the endogenous KIT receptor. This allows studies on the functional activities of both receptors in this cell population (Figure 1a) .
To test the potential of FLT3 to reconstitute the KIT-dependent mitogenic deficiency present in W mice, we derived several mast cell populations from fetal liver of homozygous W/W animals. The W/W phenotype was determined by FACS analysis using an anti-mKIT MoAb that distinguishes between +/+, W/+ and W/W origins. The absence of KIT expression at the surface of W/W cell populations (Figure 1b) , was confirmed by RT-PCR using specific KIT primers 52 (data not shown). Surface expression of the FF3 receptor on infected W/W mast cell populations was confirmed by staining with anti-FMS MoAb; percentages of expressing cells (85%) and expression levels were comparable in both W/W and wildtype transduced mast cells (Figure 1a and b) . In contrast, uninfected mast cells expressed no detectable endogenous FMS receptor (Figure 1 ). These different populations are therefore a reliable material for further functional studies. Figure  2b ) and similar proliferative indices were observed (Figure 2c  and d) . Proliferative indices in response to FF3 activation were higher (index between 1.3 and 1.6) than in the presence of IL3 (index = 1). A plateau value was reached around 200 ng/ml of added growth factor, similar to that observed with BaF/3 cells. 54 LXSN-infected mast cells (BMM Neo and FLM Neo) used as controls did not proliferate in the presence of CSF1 (Figure 2a and b) . Mast cells expressing FF3 survived after 7 days in the presence of 200 ng/ml of CSF1 (Figure 2f) , whereas either the vector-infected mast cell populations or populations cultivated without growth factors, did not (Figure 2e ). In the presence of rIL3, the growth rates of vector-infected or FF3-expressing mast cells were not significantly different ( Figure  2e) . The different FF3-expressing mast cell populations tested showed comparable proliferative responses when stimulated with either CSF1 or KL (Figure 2d) . Therefore, similar mitogenic activities can be induced in normal cultured mast cells upon activation of either the FLT3 kinase domain, via FF3, or of the KIT pathway.
To define whether FF3-mediated mitogenicity can bypass the KIT defect in W/W mutant mast cells, we derived FF3 expressing mast cells from fetal livers of W/W mice (FLMW FF3). FLMW FF3 mast cells proliferated in the presence of CSF1, whereas LXSN-infected W/W mast cells (FLMW Neo) did not (Figure 3a ). Experiments performed on three different FLMW mast cell populations showed a CSF1 response often FF3 infected mast cells proliferate in response to CSF1. (a) 3 H-thymidine uptake of vector-infected IL3-derived bone marrow mast cells (BMM) in response to different concentrations (800 ng/ml to 25 ng/ml) of CSF1 (᭺), KL (800 ng/ml to 25 ng/ml) (̆), and IL3 either from X63-CM (4% down to 0.125%) () or purified rmIL3 (5 ng/ml to 0.15 ng/ml) (). The data shown in c.p.m. represent the averages of triplicates (mean ± s. higher than for wild-type cells with IL3, and at lower CSF1 concentrations (Figure 3b ). Like FLM FF3 cells, FLMW FF3 cells survived and grew for a long period of time in the presence of CSF1 (Figure 3d ). Both FLMW Neo cells and FLMW FF3 cells died after a short period of time in the absence of any added growth factor (Figure 3c ). Therefore the FF3 receptor provides a mitogenic signal to W/W cultured mast cells, which overrules the KIT mitogenic defect.
FLT3 is able to induce the in vitro maturation of mast cells
Bone marrow-derived cultured mast cells can mature into a population presenting histochemical phenotypes of connective tissue mast cells upon in vitro fibroblast coıculture assays. 20, 21, 55 Maturation is dependent on a functional KIT receptor; 56 alternatively it is also mimicked by incubation of the mast cells with purified KL, but only upon IL3 withdrawal. 25 The maturation process can be monitored by the stage specific expression of mast cell proteases (MCP) from an immature to a more mature phenotype: the carboxypeptidase A protease (MC-CPA), the murine mast cell protease 6 (mMCP6), and the mMCP4 protease.
25,48-50
Figure 3
Proliferative response of infected W/W mast cells to CSF1. . Cell viability was determined by trypan blue exclusion. FLM cells were washed three times and then cultured for 7 days, with an additional feeding at day 4 with the same medium. Cell numbers represent averages of three independent measurements of a representative culture and experiments were repeated on three independent mast cell populations (FLM W1, W2 and W10) with similar results.
To investigate the ability of FLT3 to induce maturation, and substitute for KIT activity, FLM cells were tested in an in vitro maturation assay in the presence of different cytokines (IL3, KL and CSF1). As described by others, 25 after 3 weeks of continuous culture in the presence of KL, FLM Neo or FLM FF3 cells expressed the mMCP4 transcript (Figure 4) . mMCP4 was also expressed in FLM FF3 cells cultivated in the presence of CSF1. The levels of expression of mMCP6 were higher in FLM FF3 cells treated with CSF1 than with IL3. In contrast, both vector-infected and FLM FF3 cells did not express mMCP4 upon IL3 culture.
The MC-CPA protease is normally expressed by cultured mast cells; its levels of expression do not vary under different culture conditions. 25 Thus, MC-CPA was used as a control of expression in RT-PCR reactions (Figure 4) . These results show that FLT3 activity mediated by the FF3 receptor can substitute for KIT-mediated maturation of cultured mast cells.
The IL3 receptor shows synergistic mitogenic activity with KIT in mast cells, but not with FLT3
The KIT and FLT3 ligands were shown to act synergistically with other cytokines on progenitor cells. 10, 11, [57] [58] [59] The costimulation of cultured mast cells with KL and IL3 led to a In vitro maturation of mast cells monitored by expression of mast cell proteases. Samples of total RNA extracted from vectorinfected or FF3-infected FLM cells cultured in the presence of IL3 (1% of X63-CM), KL (250 ng/ml) and CSF1 (200 ng/ml) were subjected to RT-PCR (35 cycles) with primer sets specific for the different mast cell proteases. PCR parameters were as follows: denaturation, 94°C for 1 min, annealing, 55°C for 1 min and elongation, 72°C for 1 min. The resulting products were then assessed for their relative sizes by agarose gel electrophoresis followed by hybridization with specific In contrast, when costimulated with IL3 and CSF1, FLM FF3 cells showed comparable proliferative responses upon IL3 + CSF1 costimulation and CSF1 treatment alone (indices: 1.7 and 1.6, respectively). These results point to distinct interactions between the IL3 receptor and its transduction pathway on one side, and the KIT and FLT3 pathways, and show that FLT3 cannot substitute for all the KIT-dependent functions in mast cells.
FLT3 does not mimic KIT-mediated adhesion of mast cells to a fibronectin matrix KIT mediates adhesion of mast cells to a fibronectin matrix by activating the fibronectin receptors. [27] [28] [29] In order to determine whether adhesion can be mediated by the FLT3 receptor, mast cells expressing FF3 were introduced in an adhesion assay.
Mast cells did not interact with the fibronectin matrix without growth factor activation, as reported, 46 whereas 10 to 15% of Neo or FF3-expressing mast cells from wild-type or W/W origins, adhered to fibronectin when treated with IL3 ( Figure  6 ). With an optimal dose of KL (determined for each of the three cytokines tested in a time-dependent experiment, data not shown), up to 30% of FLM Neo or FLM FF3 cells adhered to the matrix, whereas FLMW Neo and FLMW FF3 cells did not adhere (Figure 6 ), and as described. 46 CSF1 did not induce adhesion of either FF3-expressing wild-type or W/W mast cells ( Figure 6 ). These experiments revealed a functional difference in the substitution of KIT by FF3 in mast cells.
Discussion
Ectopic expression of the FF3 receptor, containing the FLT3 kinase activity, in either wild-type or W mutant cultured mast cells demonstrates that FLT3 can substitute for KIT receptor 
Figure 6
Growth factor-induced adhesion of FLM cells to fibronectin. 51 Cr-labeled FLM cells were incubated in 96-well plates coated with fibronectin in the absence of growth factor (No GF) or in the presence of either IL3 (2% of X63-CM), CSF1 (500 ng/ml) or KL (100 ng/ml). Thirty minutes was determined as the incubation time giving the maximal response for each growth factor. Results are presented as the fraction of c.p.m. bound relative to total c.p.m. Bars represent the average of triplicates (mean ± s.d.). Similar results were obtained in three different experiments with independent mast cell populations.
to promote a mitogenic response in these cells, a mitogenic response mediated by CSF1, due to the chimeric nature of the FF3 receptor. Mitogenic responses are under the control of FF3 activation, which suggests that this substitution occurs through mitogenic signaling substrate(s) shared by KIT and FLT3. It has been already reported that ectopic expression of FMS, another class III RTK, complements mitogenesis and survival of such populations. 45 Therefore, physiological mitogenic signaling substrates for FLT3, FMS and KIT, are present in mast cells and these shared molecules could act upon the three RTK mitogenic pathways.
Signaling mediated by RTK involves association of the activated RTK with intracellular signaling molecules. Cytoplasmic proteins involved in mitogenic pathways have been largely described for KIT, FMS and FLT3, [30] [31] [32] [33] [34] 60, 61 although few of them were reported to be involved in a pathway common to all three RTK. Mutated receptors, deficient in different substrate binding sites, will be useful in the description of such pathways.
Both KIT and FF3 receptors induced terminal maturation of cultured mast cells as monitored by the expression of the mMCP4 protease, implying that shared substrate and/or pathway could be involved in very specialized functions such as maturation/differentiation and regulation of target gene expression.
Beside the common signaling molecules involved in mitogenic and in maturation functions observed in FF3-infected mast cells, differences in signaling were suggested by analysis of the cytokine responses of these cells. In contrast to the known synergy between the IL3 and KL signaling/activation pathways, 62 no synergistic effect was observed in FF3-infected mast cells, as shown by the similar proliferative indices of these cells upon CSF1 addition, with or without IL3 costimulation. These results suggest that the FLT3 receptor could: (1) alternatively compete for IL3 receptor substrates; (2) inhibit IL3-dependent signaling; or (3) downregulate IL3 receptor expression in mast cells. Thus, KIT and FLT3 show different behaviors with regard to IL3 activation that could suggest differences in the respective transduction pathways.
Adhesion to extracellular matrix has been described as another feature of members of the class III RTK. KIT activation leads to cellular adhesion via fibronectin, and involves mobilization of the VLA-4 (␣4␤1) and VLA-5 (␣5␤1) integrins. 27, 28 This mechanisms has been related to a regulation process involving independent activations of PI3Ј kinase and phospholipase C gamma (PLC␥). Both KIT and PDGF␤-R are associated with PLC␥ and PI3Ј kinase, whereas FLT3 shows an association with PI3Ј kinase only. [30] [31] [32] [33] 63, 64 In this study, we showed that FLT3 is unable to promote adhesion of mast cells to a fibronectin matrix. It is not known whether this results from either the lack of PLC␥ activity or from the different location, at the C-terminus sequence of the SH2-p85-PI3Ј kinase binding site (Tyr 958) of FLT3 64 compared to other class III RTK. [65] [66] [67] Alternatively, because this phosphorylated tyrosine residue is also a docking site for the GRB2 adaptator molecule (Beslu et al manuscript in preparation), competitive association could titrate this site for one of the substrate and hide its associated function.
The results presented here show that ectopic expression on mast cells of structurally related receptors provides a way to analyze the putative signaling molecules involved in the specific functions that they carried out. We showed that FLT3 can substitute for the mitogenic and maturating/differentiating functions of KIT, indicating that both receptors share signaling substrates. In contrast, discrete functions, such as synergy between growth factors and cellular adhesion, are specifically associated with the KIT receptor in mast cells. These results demonstrate that distinct cytoplasmic substrates are likely involved in the crosstalk between these two growth factor receptors and in signaling via adhesion molecules. They also suggest that these last cytoplasmic substrates should be different from the shared substrates involved in the mitogenic and maturating functions.
